uniQure NV (QURE)
6.055
+0.48
(+8.71%)
USD |
NASDAQ |
Nov 05, 16:00
6.055
0.00 (0.00%)
After-Hours: 18:32
uniQure Total Liabilities (Quarterly): 633.74M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 633.74M |
| March 31, 2024 | 623.30M |
| December 31, 2023 | 624.02M |
| September 30, 2023 | 602.77M |
| June 30, 2023 | 589.45M |
| March 31, 2023 | 218.23M |
| December 31, 2022 | 228.96M |
| September 30, 2022 | 217.06M |
| June 30, 2022 | 214.72M |
| March 31, 2022 | 211.15M |
| December 31, 2021 | 213.40M |
| September 30, 2021 | 183.87M |
| June 30, 2021 | 150.66M |
| March 31, 2021 | 135.16M |
| December 31, 2020 | 96.49M |
| September 30, 2020 | 122.61M |
| June 30, 2020 | 119.84M |
| March 31, 2020 | 119.10M |
| December 31, 2019 | 125.57M |
| September 30, 2019 | 121.36M |
| June 30, 2019 | 121.02M |
| March 31, 2019 | 111.88M |
| December 31, 2018 | 94.30M |
| Date | Value |
|---|---|
| September 30, 2018 | 81.21M |
| June 30, 2018 | 90.12M |
| March 31, 2018 | 91.98M |
| December 31, 2017 | 120.28M |
| September 30, 2017 | 119.38M |
| June 30, 2017 | 130.68M |
| March 31, 2017 | 123.91M |
| December 31, 2016 | 126.63M |
| September 30, 2016 | 132.78M |
| June 30, 2016 | 136.28M |
| March 31, 2016 | 137.83M |
| December 31, 2015 | 134.74M |
| September 30, 2015 | 139.75M |
| June 30, 2015 | 126.75M |
| March 31, 2015 | 61.03M |
| December 31, 2014 | 64.09M |
| September 30, 2014 | 63.61M |
| June 30, 2014 | 63.32M |
| March 31, 2014 | 53.58M |
| December 31, 2013 | 46.13M |
| September 30, 2013 | 43.65M |
| December 31, 2012 | 7.955M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
96.49M
Minimum
Dec 2020
633.74M
Maximum
Jun 2024
285.79M
Average
213.40M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| ProQR Therapeutics NV | 91.32M |
| Merus NV | 141.42M |
| argenx SE | -- |
| Pharming Group | 199.72M |
| Pharvaris NV | 20.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 730.85M |
| Shareholders Equity (Quarterly) | 97.11M |
| Debt to Equity Ratio | 1.056 |
| Current Ratio | 7.357 |
| Net Debt Paydown Yield | 0.07% |